[ad_1]
A big new research means that Ozempic and Wegovy don’t enhance the chance of suicidal ideas, a possible facet impact that has prompted regulatory investigations in america and Europe.
Each medicine comprise the identical energetic ingredient, semaglutide, and are in a household of medicines generally known as GLP-1 receptor agonists, which may help management blood sugar ranges and scale back starvation. Regulators within the United States, Europe, and the UK have mentioned they’re investigating circumstances of suicidal ideas (additionally known as suicidal ideation) reported in some individuals who took Ozempic, Wegovy, and different GLP-1 medicine.
Within the new research of greater than 1.8 million U.S. sufferers, nonetheless, folks on Wegovy and Ozempic had a 49 % to 73 % decrease danger of suicidal ideas than people who had been taking different medicines for weight reduction or kind 2 diabetes, based on outcomes revealed January 5 in Nature Medication.
“These findings sign preliminary proof for the security of semaglutide for these with psychological well being circumstances, who could also be at larger danger of experiencing hurt from unintended effects that trigger suicidal ideas,” says the senior research writer, Rong Xu, PhD, the director of the middle for synthetic intelligence in drug discovery at Case Western Reserve College in Cleveland.
Decrease Danger of Suicidal Ideas With Semaglutide
Researchers examined digital well being information over the six months after folks had been prescribed semaglutide or a unique treatment for weight reduction or for kind 2 diabetes.
Practically 1.6 million members took semaglutide or one other medication for kind 2 diabetes. For these folks, 0.13 % on semaglutide and 0.36 % given different medicine skilled suicidal ideas for the primary time through the interval examined within the research.
When folks had a historical past of suicidal ideas, 10 % on semaglutide and 18 % given totally different medicines had recurrent suicidal ideas through the six months.
Amongst greater than 240,000 members prescribed medicines for weight reduction, 0.11 % of these on semaglutide had suicidal ideas for the primary time, in contrast with 0.43 % for people taking totally different weight reduction medicine.
When weight reduction sufferers already had a historical past of suicidal ideas, 7 % on semaglutide skilled recurrent issues with this, in contrast with 14 % of individuals prescribed totally different weight reduction medicine.
The research wasn’t designed to show whether or not or how totally different GLP-1 medicine or different medicines would possibly instantly trigger or forestall suicidal ideas or behaviors.
Weight and Psychological Well being
It’s not precisely clear why there have been circumstances of suicidal ideas noticed in some folks taking medicine for weight reduction, says Nora Volkow, MD, a coauthor of the brand new research and the director of the Nationwide Institute on Drug Abuse on the Nationwide Institutes of Well being.
“Some speculate that it pertains to a removing of meals as a rewarding stimuli, or to the related modifications in peripheral hormones linked with weight reduction,” Volkow says. “The decrease degree of danger of suicidal ideation in sufferers handled with semaglutide in comparison with sufferers handled with different anti-diabetes or anti-obesity drugs might replicate the distinct mechanism of pharmacological motion and deserves additional investigation.”
Shauna Levy, MD, the medical director of the Tulane Weight Loss Middle in New Orleans, says the brand new research outcomes mirror what she’s seen along with her personal sufferers.
“These outcomes are in line with what I’ve seen from my sufferers, within the sense that they really feel happier after taking GLP-1 agonists,” says Dr. Levy, who wasn’t concerned within the new research. “I’ve not had many sufferers with suicidal ideation in my observe.”
Levy agreed that the precise cause why semaglutide would possibly imply much less danger of suicidal ideas isn’t clear. No less than initially, weight reduction will be related to improved temper, at the least partially as a result of weight problems is tied to larger charges of despair and nervousness.
RELATED: Sad With Your Weight? Don’t Low cost Psychological Well being and Motivation
However extra analysis is required to pinpoint the exact cause for temper shifts related to GLP-1 medicine typically or with semaglutide particularly.
Within the meantime, Levy says the brand new research outcomes gained’t change how she treats sufferers. “It’s nonetheless extremely necessary to observe sufferers fastidiously for any preexisting circumstances or any modifications in psychological well being following utilization of GLP-1 agonists,” Levy says. “It’s important that sufferers who’re taking GLP-1 agonists are adopted carefully by a medical skilled.”
[ad_2]
Leave a Reply